Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson’s disease and depression

Small molecules that increase the presynaptic function of aminergic cells may provide neuroprotection in Parkinson’s disease as well as treatments for attention deficit hyperactivity disorder (ADHD) and depression. Model genetic organisms such as Drosophila melanogaster may enhance the detection of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawal, Hakeem O., Terrell, Ashley, Lam, Hoa A., Djapri, Christine, Jang, Jennifer, Hadi, Richard, Roberts, Logan, Shahi, Varun, Chou, Man-Ting, Biedermann, Traci, Huang, Brian, Lawless, George M., Maidment, Nigel T., Krantz, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610854/
https://www.ncbi.nlm.nih.gov/pubmed/23229049
http://dx.doi.org/10.1038/mp.2012.170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610854/
https://www.ncbi.nlm.nih.gov/pubmed/23229049
http://dx.doi.org/10.1038/mp.2012.170

Ejemplares similares